SEARCH

SEARCH BY CITATION

References

  • ASAKAWA, M., TAKANO, H., NAGAI, T., UOZUMI, H., HASEGAWA, H., KUBOTA, N., SAITO, T., MASUDA, Y., KADOWAKI, T. & KOMURO, I. (2002). Peroxisome proliferator-activated receptor gamma plays a critical role in inhibition of cardiac hypertrophy in vitro and in vivo. Circulation, 105, 12401246.
  • BAUERSACHS, J., BOULOUMIE, A., FRACCAROLLO, D., HU, K., BUSSE, R. & ERTL, G. (1999). Endothelial dysfunction in chronic myocardial infarction despite increased vascular endothelial nitric oxide synthase and soluble guanylate cyclase expression: role of enhanced vascular superoxide production. Circulation, 100, 292298.
  • BAUERSACHS, J., GALUPPO, P., FRACCAROLLO, D., CHRIST, M. & ERTL, G. (2001). Improvement of left ventricular remodeling and function by hydroxymethylglutaryl coenzyme a reductase inhibition with cerivastatin in rats with heart failure after myocardial infarction. Circulation, 104, 982985.
  • BISHOP-BAILEY, D. (2000). Peroxisome proliferator-activated receptors in the cardiovascular system. Br. J. Pharmacol., 129, 823834.
  • BOZKURT, B., KRIBBS, S.B., CLUBB JR, F.J., MICHAEL, L.H., DIDENKO, V.V., HORNSBY, P.J., SETA, Y., ORAL, H., SPINALE, F.G. & MANN, D.L. (1998). Pathophysiologically relevant concentrations of tumor necrosis factor-alpha promote progressive left ventricular dysfunction and remodeling in rats. Circulation, 97, 13821391.
  • BRYANT, D., BECKER, L., RICHARDSON, J., SHELTON, J., FRANCO, F., PESHOCK, R., THOMPSON, M. & GIROIR, B. (1998). Cardiac failure in transgenic mice with myocardial expression of tumor necrosis factor-alpha. Circulation, 97, 13751381.
  • BUCHANAN, T.A., Meehan, W.P., JENG, Y.Y., YANG, D., CHAN, T.M., NADLER, J.L., SCOTT, S., RUDE, R.K. & HSUEH, W.A. (1995). Blood pressure lowering by pioglitazone. Evidence for a direct vascular effect. J. Clin. Invest., 96, 354360.
  • DELEA, T., HAGIWARA, M., EDELSBERG, J. & OSTER, G. (2002). Exposure of glitazone antidiabetics and risk of heart failure among persons with type 2 diabetes: a retrospective population-based cohort analysis. JACC, 39, Abstract 858-3.
  • DELERIVE, P., MARTIN-NIZARD, F., CHINETTI, G., TROTTEIN, F., FRUCHART, J.C., NAJIB, J., DURIEZ, P. & STAELS, B. (1999). Peroxisome proliferator-activated receptor activators inhibit thrombin-induced endothelin-1 production in human vascular endothelial cells by inhibiting the activator protein-1 signaling pathway. Circ. Res., 85, 394402.
  • DUCHARME, FRANTZ, S., AIKAWA, M., RABKIN, E., LINDSEY, M., ROHDE, L.E., SCHOEN, F.J., KELLY, R.A., WERB, Z., LIBBY, P. & LEE, R.T. (2000). Targeted deletion of matrix metallaproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction. J. Clin. Invest., 106, 5562.
  • FRACCAROLLO, D., HU, K., GALUPPO, P., GAUDRON, P. & ERTL, G. (1997). Chronic endothelin receptor blockade attenuates progressive ventricular dilation and improves cardiac function in rats with myocardial infarction: possible involvement of myocardial endothelin system in ventricular remodeling. Circulation, 96, 39633973.
  • FRANTZ, S., KELLY, R.A. & BOURCIER, T. (2001). Role of TLR-2 in the activation of nuclear factor-kappa B by oxidative stress in cardiac myocytes. J. Biol. Chem., 276, 51975203.
  • FRANTZ, S., KOBZIK, L., KIM, Y.D., FUKAZAWA, R., MEDZHITOV, R., LEE, R.T. & KELLY, R.A. (1999). Toll4 (TLR4) expression in cardiac myocytes in normal and failing myocardium. J. Clin. Invest., 104, 271280.
  • IKEDA, H., TAKETOMI, S., SUGIYAMA, Y., SHIMURA, Y., SOHDA, T., MEGURO, K. & FUJITA, T. (1990). Effects of pioglitazone on glucose and lipid metabolism in normal and insulin resistant animals. Arzneimittelforschung, 40, 156162.
  • JIANG, C., TING, A.T. & SEED, B. (1998). PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines. Nature, 391, 8286.
  • JUNQUEIRA, L.C., BIGNOLAS, G. & BRENTANI, R.R. (1979). Picrosirius staining plus polarization microscopy, a specific method for collagen detection in tissue sections. Histochem. J., 11, 447455.
  • KAPLAN, F., AL-MAJALI, K. & BETTERIDGE, D.J. (2001). PPARS, insulin resistance and type 2 diabetes. J. Cardiovasc. Risk, 8, 211217.
  • KUBOTA, T., MCTIERNAN, C.F., FRYE, C.S., SLAWSON, S.E., LEMSTER, B.H., KORETSKY, A.P., DEMETRIS, A.J. & FELDMAN, A.M. (1997). Dilated cardiomyopathy in transgenic mice with cardiac-specific overexpression of tumor necrosis factor-alpha. Circ. Res., 81, 627635.
  • LYGATE, C.A., HULBERT, K., MONFARED, M., COLE, M., CLARKE, K. & NEUBAUER, S. (2003). The PPARg-activator rosiglitazone does not alter remodeling but increases mortalitzy in rats post-myocardial infarction. Cardiovasc. Res., 58, 632637.
  • MARX, N. & HOMBACH, V. (2001). [Peroxisome proliferator-activated receptors (PPARs) in the vessel wall: new regulators of gene expression in vascular cells]. Z. Kardiol., 90, 470477.
  • MARX, N., SCHONBECK, U., LAZAR, M.A., LIBBY, P. & PLUTZKY, J. (1998). Peroxisome proliferator-activated receptor gamma activators inhibit gene expression and migration in human vascular smooth muscle cells. Circ. Res., 83, 10971103.
  • MCMURRAY, J.J., RAY, S.G., ABDULLAH, I., DARGIE, H.J. & MORTON, J.J. (1992). Plasma endothelin in chronic heart failure. Circulation, 85, 13741379.
  • ROHDE, L.E., DUCHARME, A., ARROYO, L.H., AIKAWA, M., SUKHOVA, G.H., LOPEZ-ANAYA, A., MITCHELL, K., LIBBY, P. & LEE, R.T. (1999). Matrix metalloproteinase inhibition attenuates early left ventricular enlargement after experimental myocardial infarction in mice. Circulation, 99, 30633070.
  • SCHOONJANS, K. & AUWERX, J. (2000). Thiazolidinediones: an update. Lancet, 355, 10081010.
  • SHIOMI, T., TSUTSUI, H., HAYASHIDANI, S., SUEMATSU, N., IKEUCHI, M., WEN, J., ISHIBASHI, M., KUBOTA, T., EGASHIRA, K. & TAKESHITA, A. (2002). Pioglitazone, a peroxisome proliferator-activated receptor-gamma agonist, attenuates left ventricular remodeling and failure after experimental myocardial infarction. Circulation, 106, 31263132.
  • SIDHU, J.S. & KASKI, J.C. (2001). Peroxisome proliferator activated receptor gamma: a potential therapeutic target in the management of ischaemic heart disease. Heart, 86, 255258.
  • SIMONCIKOVA, P., WEIN, S., GASPERIKOVA, D., UKROPEC, J., CERTIK, M., KLIMES, I. & SEBOKOVA, E. (2002). Comparison of the extrapancreatic action of gamma-linolenic acid and n-3 PUFAs in the high fat diet-induced insulin resistance. Endocr. Regul., 36, 143149.
  • TAKANO, H., NAGAI, T., ASAKAWA, M., TOYOZAKI, T., OKA, T., KOMURO, I., SAITO, T. & MASUDA, Y. (2000). Peroxisome proliferator-activated receptor activators inhibit lipopolysaccharide-induced tumor necrosis factor-alpha expression in neonatal rat cardiac myocytes. Circ. Res., 87, 596602.
  • TANG, W.H., FRANCIS, G.S., HOOGWERF, B.J. & YOUNG, J.B. (2003). Fluid retention after initiation of thiazolidinedione therapy in diabetic patients with established chronic heart failure. J. Am. Coll. Cardiol., 41, 13941398.
  • TESTA, M., YEH, M., LEE, P., FANELLI, R., LOPERFIDO, F., BERMAN, J.W. & LEJEMTEL, T.H. (1996). Circulating levels of cytokines and their endogenous modulators in patients with mild to severe congestive heart failure due to coronary artery disease or hypertension. J. Am. Coll. Cardiol., 28, 964971.
  • TORRE-AMIONE, G., KAPADIA, S., BENEDICT, C., ORAL, H., YOUNG, J.B. & MANN, D.L. (1996). Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the Studies of Left Ventricular Dysfunction (SOLVD). J. Am. Coll. Cardiol., 27, 12011206.
  • TSUJI, T., MIZUSHIGE, K., NOMA, T., MURAKAMI, K., OHMORI, K., MIYATAKE, A. & KOHNO, M. (2001). Pioglitazone improves left ventricular diastolic function and decreases collagen accumulation in prediabetic stage of a type II diabetic rat. J. Cardiovasc. Pharmacol., 38, 868874.
  • WAYMAN, N.S., HATTORI, Y., MCDONALD, M.C., MOTA-FILIPE, H., CUZZOCREA, S., PISANO, B., CHATTERJEE, P.K. & THIEMERMANN, C. (2002). Ligands of the peroxisome proliferator-activated receptors (PPAR-gamma and PPAR-alpha) reduce myocardial infarct size. FASEB J., 16, 10271040.
  • YAMAMOTO, K., OHKI, R., LEE, R.T., IKEDA, U. & SHIMADA, K. (2001). Peroxisome proliferator-activated receptor gamma activators inhibit cardiac hypertrophy in cardiac myocytes. Circulation, 104, 16701675.
  • YUE, T.-L., CHEN, J., BAO, W., NARAYANAN, P., BRIL, A., JIANG, W., LYSKO, P., GU, J.-L., BOYCE, R., ZIMMERMAN, D., HART, T., BUCKINGHAM, R. & OHLSTEIN, E. (2001). In vivo myocardial protection from ischemia/reperfusion injury by the peroxisome proliferator-activated receptor-agonist rosiglitazone. Circulation, 104, 25882594.